Evans syndrome complicating fludarabine treatment for advanced B-CLL [1]

British Journal of Haematology

Volumn 99, Issue 3, 1997, Pages 706-713

  Shvidel, L ^a   Shtarlid, M ^a   Klepfish, A ^a   Sigler, E ^a   Berrebi, A ^a  

^a KAPLAN MEDICAL CENTER   (Israel)

Author keywords

Autoimmune haemolytic anaemia; Chronic lymphocytic leukaemia; Evans syndrome; Fludarabine; Immune thrombocytopenia

Indexed keywords

AUTOANTIBODY; CHLORAMBUCIL; CYCLOSPORIN; FLUDARABINE; PREDNISONE;

ADULT; AUTOIMMUNE HEMOLYTIC ANEMIA; BONE MARROW SUPPRESSION; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; DISEASE COURSE; DRUG CYTOTOXICITY; DRUG POTENCY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOLOGY; INTRAVENOUS DRUG ADMINISTRATION; LETTER; MALE; PRIORITY JOURNAL; THROMBOCYTE COUNT;

ANEMIA, HEMOLYTIC; ANTINEOPLASTIC AGENTS; HUMANS; LEUKEMIA, B-CELL, CHRONIC; MALE; MIDDLE AGED; SYNDROME; THROMBOCYTOPENIA; VIDARABINE;

EID: 0030714708     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (3)